ACCPL — Accretion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Accretion Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	3.75	0.364	0.916	0.508
Net Total Accounts Receivable
Net Total Receivables	45.7	66.6	68.5	128
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	119	145	216	335
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	58.4	60.1	52.7	60.9
Long Term Notes Receivable
Other Long Term Assets
Total Assets	177	206	270	399
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	117	138	147	232
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	147	167	217	246
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	30.8	38.4	53.5	153
Total Liabilities & Shareholders' Equity	177	206	270	399
Total Common Shares Outstanding